Allergy Therapeutics (AGY) RNS Announcements

Add to Alert list
Date Time Source Announcement
18 Mar 2019 04:36 PM
RNS
Price Monitoring Extension
18 Mar 2019 11:30 AM
EQS
Allergy Therapeutics (AGY): Take an objective view
18 Mar 2019 11:05 AM
RNS
Second Price Monitoring Extn
18 Mar 2019 11:00 AM
RNS
Price Monitoring Extension
18 Mar 2019 09:05 AM
RNS
Second Price Monitoring Extn
18 Mar 2019 09:00 AM
RNS
Price Monitoring Extension
18 Mar 2019 07:00 AM
RNS
Top Line Phase III results from B301 trial
06 Mar 2019 12:10 PM
EQS
Allergy Therapeutics (AGY): Strong operating pe...
06 Mar 2019 07:00 AM
RNS
Interim Results
17 Jan 2019 09:56 AM
EQS
Allergy Therapeutics (AGY): Trading update: gai...
16 Jan 2019 07:00 AM
RNS
Trading Update & Notice of Results
29 Nov 2018 05:59 PM
RNS
Holdings in Company
27 Nov 2018 01:12 PM
RNS
Result of AGM
27 Nov 2018 07:00 AM
RNS
AGM Trading Update
12 Nov 2018 12:00 PM
RNS
Presentation at Jefferies Healthcare Conference
08 Nov 2018 07:00 AM
RNS
Directorate Change
07 Nov 2018 06:06 PM
RNS
Holdings in Company
02 Nov 2018 07:00 AM
RNS
Grant of Awards under Long Term Incentive Plan
24 Oct 2018 01:25 PM
RNS
Holdings in Company
24 Oct 2018 07:00 AM
RNS
Director/PDMR Shareholding
23 Oct 2018 05:29 PM
RNS
Annual Report and Accounts
23 Oct 2018 03:28 PM
RNS
Holdings in Company
27 Sep 2018 07:15 AM
EQS
Allergy Therapeutics (AGY): 2018 full-year resu...
26 Sep 2018 07:00 AM
RNS
Preliminary Results
08 Aug 2018 07:00 AM
RNS
Notice of Results
27 Jul 2018 05:26 PM
RNS
Holding(s) in Company
26 Jul 2018 12:02 PM
RNS
Holding(s) in Company
19 Jul 2018 10:19 AM
RNS
Results of Placing and Subscription
19 Jul 2018 07:00 AM
RNS
Proposed placing & subscription to raise £10.6m
16 Jul 2018 08:53 AM
RNS
BLOCK LISTING SIX MONTHLY RETURN
13 Jul 2018 09:40 AM
EQS
Allergy Therapeutics (AGY): Steady performance ...
12 Jul 2018 07:00 AM
RNS
Trading Update
25 Jun 2018 07:52 AM
RNS
Positive data of Pollinex Quattro Grass vaccine
29 May 2018 07:00 AM
RNS
Positive data with house-dust mite immunotherapy
21 May 2018 12:25 PM
EQS
Allergy Therapeutics (AGY): Opening the door to...
21 May 2018 07:00 AM
RNS
Positive top-line results from Grass Ph II study
14 May 2018 07:00 AM
RNS
Publication of MCT Adjuvant Data
16 Mar 2018 03:38 PM
RNS
Grant of Awards under Long Term Incentive Plan
16 Mar 2018 12:53 PM
RNS
Director/PDMR Shareholding
07 Mar 2018 09:30 AM
RNS
Hardman: Clinical development towards submission
07 Mar 2018 07:00 AM
RNS
Interim Results
28 Feb 2018 07:00 AM
RNS
Polyvac® Peanut CMO appointed
12 Feb 2018 07:00 AM
RNS
Completion of recruitment in PQ Grass Ph II trial
02 Feb 2018 07:15 AM
RNS
Hardman Research: Growth in a tough market
31 Jan 2018 07:00 AM
RNS
Trading Update
10 Jan 2018 03:19 PM
RNS
Holdings in Company
09 Jan 2018 07:00 AM
RNS
PQ Birch Phase III trial completes recruitment
12 Dec 2017 07:00 AM
RNS
Co-development agreement with Ergomed plc
07 Dec 2017 05:08 PM
RNS
Holding(s) in Company
22 Nov 2017 11:36 AM
RNS
Result of AGM
UK 100

Latest directors dealings